November 22-23 2023 Lyon, France
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Booth N°5 | www.sanofi.fr
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Booth N°23 | www.boehringer-ingelheim.com
Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services.
Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results. Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.
Booth N°6 | www.bio-techne.com
Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. Croda Pharma's formulation and regulation expertise enables the next generation of drug delivery systems. We offer high purity pharmaceutical excipients to enhance delivery, efficacy, and stability of actives as well as highly performing vaccine adjuvants and in-house formulation expertise to aid in navigating drug and vaccine formulation challenges. Moreover, our lipid portfolio supports the delivery of mRNA-based vaccines.
With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda Pharma demonstrates confidence in both excipient quality and supply chain security.
Booth N°10 | www.crodapharma.com | Thomas.vinos-poyo@croda.com
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, metabolic and infectious diseases.With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda Pharma demonstrates confidence in both excipient quality and supply chain security.
Booth N°28 | www.evotec.com | info@evotec.com
Promega is a worldwide leader in biochemistry, cellular and molecular biology with the development of innovative technologies for the Life Sciences.
Based on bioluminescent technology innovations, Promega offers a broad portfolio of functional reporter bioassays, primary cell killing assays and immunoassays, used for R&D or QC batch release of therapeutic antibodies and cell/gene therapies.
With their new bioassay development and qualification services, Promega can help accelerate your biologics drug discovery and development workflow.
Booth N°32 | france.promega.com | FR.support@promega.com
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.
Revvity is pushing the limits of what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more.
With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.
Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.
Booth N°2 | www.revvity.com | delphine.coiffier@perkinelmer.com
Sino Biological is dedicated to providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery. With the largest validated recombinant protein bank (6000+), a broad range of antigens are covered, including viral proteins, cytokines and growth factors, immune checkpoints, antigens for CAR-T cell therapy, Fc receptors, biomarker proteins, etc., as well as a comprehensive collection of high-quality mono- and polyclonal antibodies.
Based on our rich experiences and expertise with over 5000 projects completed, several robust recombinant protein expression platforms and antibody discovery methods have been established for customized contracted research projects.
Booth N°31 | www.sinobiological.com | order_eu@sinobiological.com
ACROBiosystems is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business model innovation. They offer a wide array of life sciences tools, reagents, and instruments to serve customers spanning over 7000 pharmaceuticals, CRO/ CDMO, research institutions, and hospitals across 70 countries.
Booth N°26 | www.acrobiosystems.com | info@acrobiosystems.com
Advanced Instruments is a global company offering a novel portfolio of analytical tools including, OsmoTECH®, a robust line of micro-osmometers to support bioprocessing and quality control (QC), and Solentim, a portfolio of best in class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies.
Our Solentim portfolio enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. This enables our customers to use these clones and have the documentation they were clonally-derived to confidently form their Master Cell Banks.
Booth N°27 | www.aicompanies.com
Created in 2012, following the French initiative of Technology Research Institutes, BIOASTER is a non-for-profit foundation developing a unique technological and innovative model to sup-port the latest challenges in microbiology. In particular, BIOASTER uses and develops high value technological innovations that accelerate development of medical solutions for populations and personalized medicine. The aim of BIOASTER is to bring together academic, industry and its capacities and specific knowledge to develop and execute high impact collaborative projects requiring industry compatible innovative technologies.
Key figures:
• 4 fields of expertise: antimicrobials, diagnostics, microbiome, vaccines
• BSL2 & BSL3 laboratories in Lyon and Paris
• 110+ employees, including 80% of scientific experts, 15 nationalities
• 330+ research contracts, involving 93 private partners, 54 public partners.
Booth N°30 | www.bioaster.org | olivier.charzat@bioaster.org
Expert in immunotechnologies since 1980, BIOTEM is a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) which provides high added value services for the development / production of custom monoclonal antibodies and immunoassays (ELISA & LFIA).
The company has been the privileged partner of almost 500 prestigious industrial and academic laboratories for their projects in fundamental research, development of improved diagnostics or promising therapeutic tools.
Booth N°30 | www.biotem-antibody.com/ | info@biotem.fr
30-year NCD/toxicology consulting, due diligence, ocular, cardiovasc, fundraising, partnerships. NCD plan, CRO selection, monitoring, reporting & submission to regulatory authorities (mainly EU/US). Global dvpt strategy In/outlicensing/partnership Due Dil support (startup, big pharma, investors).
Booth N°3 | www.capeval-pharma.com
ICTA is an international full-service Contract Research Organisation with headquarters in France that provides product development services for the pharmaceutical and medical device industries across Europe and North America. Our corporate philosophy and culture are driven by high quality services based on innovation, work integrity, and a strong focus on solutions.
Our aim is to help you navigate the complexities of clinical and RWE research with confidence and to provide you with solutions tailored to your needs, whether you are a big or medium-sized pharmaceutical company, a biotech or medtech company.
From early development to post-approval, we provide expert guidance to improve and accelerate the development of your product, and support it across its entire life cycle through a streamlined approach where methodology expertise and operational know-how collide.
Provider of a full-service solution from design to data analysis, ICTA multidisciplinary team provides you with insight and expertise to successfully design, plan, implement and execute your clinical study.
Booth N°24 | www.icta.fr
Integrated DNA Technologies, Inc. (IDT) is in the business of moving science forward. We are scientists working for scientists. Our innovative tools and solutions for genomics applications are breaking down barriers and inspiring you to dream big and achieve your next breakthroughs. A champion of life sciences research for more than 35 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, pharmaceutical development and synthetic biology. We take pride in having the highest standards of quality, technical expertise, and personalized customer service. IDT leads the industry in the manufacture of custom oligonucleotides for molecular biology applications. We've developed proprietary technologies for genomics applications, such as Next Generation Sequencing, CRISPR genome editing, qPCR, and RNA interference. Through our GMP services, we manufacture products used in diagnostic tests for many forms of cancer and most inherited and infectious diseases. We are continually improving IDT synthesis platforms, processing technology, and automation, as well as our rapid prototyping and custom reagent production. We are run by scientists dedicated to helping other scientists answer research questions through collaborative interaction. We serve more than 130,000 life sciences researchers in more than 100 countries and produce more than 90,000 nucleic acids daily. The versatility of our portfolio gives us a unique, product-centered sustainability focus. Our products are critical tools that help address global sustainability issues, such as biodiversity, global food security, bioremediation, and biofuels. The IDT Sustainability Award recognizes and rewards customers for research having great potential to make a global impact.
Booth N°25 | eu.idtdna.com
Science is at the heart of everything we do. We are dedicated to support and collaborate with the global scientific community in diverse ways.
The grants we award to emerging biopharma companies help bring innovation to the market and the tools & processes we develop ensure the manufacturing of innovative therapies.
With 350 years of scientific expertise, our Life Science business drives the discoveries, collaboration and solutions with the goal of accelerating access to better health worldwide.
Booth N°1 | www.sigmaaldrich.com | Sandrine Loison, sandrine.loison@merckgroup.com
PASREL-Imagerie, a consortium of research centers, provides state-of-the-art translational in vivo imaging expertise and platforms to derisk medical innovations by bringing together:
• Preclinical and clinical imaging: PET, MRI, Ultrasound, bi-photon microscopy, Multimodal Imaging, radiopharmaceuticals, etc.
• Multidisciplinary centers investigating numerous therapeutic areas such as infectious diseases,
• A rich research environment with complementary platforms.
From proof of concept in animals to development in patients, partners have the opportunity to characterize pathophysiology of diseases, efficacy of drug candidates, imaging biomarkers, compound biodistribution, and first tests before human clinical trials.
Booth N°4 | www.pasrel-imagerie.com
PROTEIGENE deals with scientifi c products and technologies since 1999.
During more than 20 years, we delivered high level technology systems like Qbot/Qpix, Clonepix FL, Fragment analyzer, ImageStreamX , SeaHorse analysers and many others.
Today, we still propose powerful systems in Single Cell analysis, Cell line development Antibody research and SPR analysis.
- Cyto-Mine by Sphere Fluidics,
- IotaSCience Platform: One system for complete cloning workfl ow,
- OPenSPR and Alto By Nicoya an aff ordable alternative to Biacore systems.
- Gergentis: Using its propietary TLA technolgy, Cergentis has recently implemented the CHOice
Kit a cost eff ective and scalable kit to select the right CHO clone by assessing in a fully integrated in-house solution transgene integrity as well as mapping and QC of integration sites.
Booth N°8 | proteigene.com
Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (NfinityTM) that encompasses DNA (NplifyTM) and RNA (NtensifyTM) manufacturing and formulation (NcapsulateTM), along with critical reagent supply, from small to larger scale, ideally for pre-clinical and clinical study or trial projects. We are a team of scientists, engineers and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. Our facilities are strategically located in Belgium and France, in the heart of Europe, benefiting from an exceptional biotech ecosystem. Quantoom Biosciences is part of Univercells, a global life sciences Group with the mission of making biologics accessible to all.
Booth N°22 | www.quantoom.com | info@quantoom.com
At the heart of your research, Voxcan accelerate the development of your innovative vaccines and anti-infectives, by performing efficacy, biodistribution and tolerability studies.
The use of non-invasive in vivo imaging (bioluminescence, fluorescence, CT) allows us to follow disease progression and/or drug biodistribution longitudinally, providing you with the most appropriate preclinical service.
Booth N°11 | www.voxcan.fr
Check the sponsors, exhibitors and partners of the previous edition HERE
Interested by a custom-made sponsorship offer? Contact us @MabDesign and @Lyonbiopôle.
Download the 2023 Sponsorship agreement
12 000€ (+VAT 20%)
Member 8 000€ (+VAT 20%)
Non-member 9 000€ (+VAT 20%)
Member 5 000€ (+VAT 20%)
Non-member 6 000€ (+VAT 20%)
Member 3 000€ (+VAT 20%)
Non-member 3 700€ (+VAT 20%)
Member 2 200€ (+VAT 20%)
Non-member 2 700€ (+VAT 20%)
Prices and further details available upon request
